跳至主要内容
临床试验/JPRN-UMIN000006217
JPRN-UMIN000006217已完成未知

Difference in effect on post-meal lipid, proinsulin, GIP and GLP-1 between Sitagliptin, Vildagliptin and Alogliptin in T2DM using DPP-4 inhibitor - Clinical study of DPP-4 inhibitor therapy on post meal lipid, proinsulin, GIP and GLP-1

Saitama Medical University0 个研究点目标入组 30 人开始时间: 2011年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who use of other DPP4 inhibitor 2)Patients who use of fibrate 3)Diabetic neuropathy 4)Severe ketosis,deabetic coma or precoma,type1diabetes 5)Severe renal dysfunction requiring hemodialysis or peritoneal dialysis 6)Severe hepatic dysfunction 7)Patients with a history of hypersensitibity to the study drug 8)Patients before or after operation, and those with severe infections or serious injury 9)Pregnant 10)Patients judged by the investigator to be ineligible for some other reason

研究者

相似试验